These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7543780)

  • 1. Differential effect of rapamycin and cyclosporin A in proliferation in a murine T cell line expressing either intermediate or high affinity receptor for IL-2.
    Rebollo A; Mérida I; Gómez J; Pitton C; Silva A; Martínez C; García A
    Cytokine; 1995 Apr; 7(3):277-86. PubMed ID: 7543780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
    Dumont FJ; Melino MR; Staruch MJ; Koprak SL; Fischer PA; Sigal NH
    J Immunol; 1990 Feb; 144(4):1418-24. PubMed ID: 1689353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin and FK506 differentially inhibit mast cell cytokine production and cytokine-induced proliferation and act as reciprocal antagonists.
    Hatfield SM; Mynderse JS; Roehm NW
    J Pharmacol Exp Ther; 1992 Jun; 261(3):970-6. PubMed ID: 1376361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Melino MR; Sigal NH
    J Immunol; 1990 Jan; 144(1):251-8. PubMed ID: 1688572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression.
    Kunz J; Hall MN
    Trends Biochem Sci; 1993 Sep; 18(9):334-8. PubMed ID: 7694398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A.
    Keicho N; Kudoh S; Yotsumoto H; Akagawa KS
    J Antibiot (Tokyo); 1993 Sep; 46(9):1406-13. PubMed ID: 7693639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis.
    Koenen HJ; Michielsen EC; Verstappen J; Fasse E; Joosten I
    Transplantation; 2003 May; 75(9):1581-90. PubMed ID: 12792519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes.
    McCarthy SA; Cacchione RN; Mainwaring MS; Cairns JS
    Transplantation; 1992 Sep; 54(3):543-7. PubMed ID: 1384186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
    Hess DA; Bird IA; Almawi WY; Rieder MJ
    J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin inhibition of interleukin-2-dependent p33cdk2 and p34cdc2 kinase activation in T lymphocytes.
    Morice WG; Wiederrecht G; Brunn GJ; Siekierka JJ; Abraham RT
    J Biol Chem; 1993 Oct; 268(30):22737-45. PubMed ID: 8226784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: sensitivity to immunosuppressants is defined by the mode of T-lymphocyte activation.
    Ryffel B; Willcocks JL; Brooks N; Woerly G
    Immunopharmacology; 1995 Sep; 30(3):199-207. PubMed ID: 8557519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T cells.
    Terada N; Lucas JJ; Szepesi A; Franklin RA; Takase K; Gelfand EW
    Biochem Biophys Res Commun; 1992 Aug; 186(3):1315-21. PubMed ID: 1380801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells.
    Cho CS; Chang Z; Elkahwaji J; Scheunemann TL; Manthei ER; Colburn M; Knechtle SJ; Hamawy MM
    Int Immunol; 2003 Nov; 15(11):1369-78. PubMed ID: 14565935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells.
    Wiederrecht GJ; Sabers CJ; Brunn GJ; Martin MM; Dumont FJ; Abraham RT
    Prog Cell Cycle Res; 1995; 1():53-71. PubMed ID: 9552353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of adult T cell leukemia-derived factor/human thioredoxin induction by FK506 and cyclosporin A: a new mechanism of immune modulation via redox control.
    Furuke K; Nakamura H; Hori T; Iwata S; Maekawa N; Inamoto T; Yamaoka Y; Yodoi J
    Int Immunol; 1995 Jun; 7(6):985-93. PubMed ID: 7577807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of rapamycin to block proliferation once resting cells have entered the cell cycle despite inactivation of p70 S6 kinase.
    Terada N; Franklin RA; Lucas JJ; Blenis J; Gelfand EW
    J Biol Chem; 1993 Jun; 268(16):12062-8. PubMed ID: 8389370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct inhibition of human CD8+ lymphocyte activation by cyclosporine A and Rapamune-Sirolimus.
    Combates NJ; Degiannis D; Raskova J; Raska K
    Clin Immunol Immunopathol; 1995 Dec; 77(3):221-8. PubMed ID: 7586731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.
    Bierer BE; Mattila PS; Standaert RF; Herzenberg LA; Burakoff SJ; Crabtree G; Schreiber SL
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9231-5. PubMed ID: 2123553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
    Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
    Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.
    Terada N; Lucas JJ; Szepesi A; Franklin RA; Domenico J; Gelfand EW
    J Cell Physiol; 1993 Jan; 154(1):7-15. PubMed ID: 8419408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.